BUDZ
WEED, Inc.0.0600
+0.0100+20%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
8.16MP/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Weed, Inc. posted no revenue for Q3 ended September 30, 2025, with operating loss shrinking 28% y/y to $66,897 (derived) from $92,649, thanks to lower general and administrative expenses and professional fees. Nine-month operating loss widened to $600,805, up 49% y/y (derived), driven by higher G&A from consulting and stock-based comp. Cash dwindled to $400 amid $75K operating burn; related-party notes payable fell to $348K after repayments, yet liabilities hit $1.05M versus $519K equity deficit. Diluted EPS of $(0.001) reconciles to 135.9M shares. Related-party funding props it up. Cash nearly gone.
10-Q
Q2 FY2025 results
Weed, Inc. posted no revenue for Q2 FY2025 ended June 30, 2025, with operating loss narrowing to $94K from $145K y/y while net loss held steady at $108K. Six-month operating expenses climbed 68% y/y to $529K, driven by $447K general and administrative, yet cash burn eased to $71K used in operations from $259K. Cash dwindled to $5K amid $345K related-party notes; equity deficit deepened to $448K. Stock comp fueled the spend. Shares dilute steadily. Going concern looms large.
10-Q
Q1 FY2025 results
Weed, Inc. posted no revenue for Q1 ended March 31, 2025, with operating loss widening to $434.7K from $167.5K y/y, driven by general and administrative expenses jumping to $383.3K from $136.6K. Net loss hit $440.5K or $(0.003) per diluted share on 132.9M weighted shares, versus $170.7K or $(0.0014) last year; the gap reflects higher stock-based compensation at $300K and interest expense. Cash drained to $3.1K from $159.4K q/q amid $71.8K operating outflow, offset by related-party note activity—net debt fell to $340.9K. Stockholders' deficit deepened to $346K. Related-party funding keeps it afloat. Losses mount fast.
10-K
FY2024 results
WEED, Inc. posted FY2024 net loss of $510,716 on zero revenue, up from $31,557 loss in 2023 due to missing the prior year's $988,375 gain on fixed asset sale from a La Veta property divestiture. Operating loss narrowed 30% y/y to $530K as G&A and professional fees dropped sharply, while cash burn eased to $416K used in operations. Cash stood at $159K by year-end amid $310K in new related-party notes, yet monthly burn persists at $45K with no revenue runway. No quarterly breakdowns disclosed. Funding shortfall stalls genomic study and hemp plans. Federal cannabis prohibition threatens research.
10-Q
Q3 FY2024 results
Weed, Inc. posted no revenue for Q3 ended September 30, 2024, with operating expenses down sharply 61% y/y to $92,649 from $238,824, driving a smaller operating loss of $92,649 versus $238,824 last year. Net loss narrowed to $95,887 from a $734,248 profit fueled by prior asset sale gains, mainly due to absent one-offs while interest expense ticked to $3,238. Cash drained to $5,311 after $279K operating outflow YTD, offset by related-party notes at $135,764 and a $3,661 defaulted note. Equity flipped negative at $88K amid $84.8M accumulated deficit. Shares steady near 126M weighted average. Cash burns fast.
IPO
Website
Employees
Sector
Industry
ACB
Aurora Cannabis Inc.
5.53+0.41
CBSTF
THE CANNABIST COMPANY HOLDINGS
0.10+0.03
CGC
Canopy Growth Corporation
1.83+0.17
CWBHF
Charlotte's Web Holdings Inc.
0.15+0.00
EDXC
ENDEXX Corp.
0.00+0.00
IMCC
IM Cannabis Corp.
1.73+0.21
LEEEF
LEEF BRANDS INC
0.22+0.02
MAJI
Marijuana Inc.
0.05-0.02
MRMD
MariMed Inc.
0.12+0.01
YCBD
cbdMD, Inc.
1.43+0.23